178 related articles for article (PubMed ID: 31590967)
21. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
Bundhun PK; Wu ZJ; Chen MH
Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
[TBL] [Abstract][Full Text] [Related]
22. [The BARI 2D study].
Mafrici A; Briguori C
G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
[No Abstract] [Full Text] [Related]
23. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
Kim LJ; King SB; Kent K; Brooks MM; Kip KE; Abbott JD; Jacobs AK; Rihal C; Hueb WA; Alderman E; Sing IR; Attubato MJ; Feit F;
JACC Cardiovasc Interv; 2009 May; 2(5):384-92. PubMed ID: 19463459
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications of the BARI 2D and COURAGE trials: overview.
Brooks MM; Boden WE; Frye RL
Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
[TBL] [Abstract][Full Text] [Related]
26. Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.
Tsujimoto T; Kajio H
J Am Heart Assoc; 2019 Jan; 8(2):e011207. PubMed ID: 30646801
[TBL] [Abstract][Full Text] [Related]
27. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
[TBL] [Abstract][Full Text] [Related]
28. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V
J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.
Dagenais GR; Lu J; Faxon DP; Bogaty P; Adler D; Fuentes F; Escobedo J; Krishnaswami A; Slater J; Frye RL;
J Am Coll Cardiol; 2013 Feb; 61(7):702-11. PubMed ID: 23410541
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.
Althouse AD; Abbott JD; Forker AD; Bertolet M; Barinas-Mitchell E; Thurston RC; Mulukutla S; Aboyans V; Brooks MM;
Diabetes Care; 2014; 37(5):1346-52. PubMed ID: 24595631
[TBL] [Abstract][Full Text] [Related]
31. Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial).
Krishnaswami A; Hardison R; Nesto RW; Sobel B;
Am J Cardiol; 2012 Jan; 109(1):36-41. PubMed ID: 21958742
[TBL] [Abstract][Full Text] [Related]
32. [Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
Störk S; Ertl G; Nitschmann S
Internist (Berl); 2010 May; 51(5):674-6. PubMed ID: 20352177
[No Abstract] [Full Text] [Related]
33. Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery.
Turgeon RD; Koshman SL; Youngson E; Pearson GJ
Pharmacotherapy; 2020 Feb; 40(2):116-124. PubMed ID: 31883378
[TBL] [Abstract][Full Text] [Related]
34. SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
Ikeno F; Brooks MM; Nakagawa K; Kim MK; Kaneda H; Mitsutake Y; Vlachos HA; Schwartz L; Frye RL; Kelsey SF; Waseda K; Hlatky MA;
J Am Coll Cardiol; 2017 Jan; 69(4):395-403. PubMed ID: 28126156
[TBL] [Abstract][Full Text] [Related]
35. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
36. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.
Pop-Busui R; Lu J; Brooks MM; Albert S; Althouse AD; Escobedo J; Green J; Palumbo P; Perkins BA; Whitehouse F; Jones TL;
Diabetes Care; 2013 Oct; 36(10):3208-15. PubMed ID: 23757426
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass in patients with type 2 diabetes: experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Sako EY; Brooks MM; Hardison RM; Schaff H; Frye RL
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1268-72. PubMed ID: 24507404
[TBL] [Abstract][Full Text] [Related]
38. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.
Jeong YJ; Ahn JM; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park H; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ; Park DW
J Am Heart Assoc; 2021 Jul; 10(14):e019834. PubMed ID: 34238026
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
40. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Shaw LJ; Cerqueira MD; Brooks MM; Althouse AD; Sansing VV; Beller GA; Pop-Busui R; Taillefer R; Chaitman BR; Gibbons RJ; Heo J; Iskandrian AE
J Nucl Cardiol; 2012 Aug; 19(4):658-69. PubMed ID: 22527794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
